A Study of Ramucirumab (LY3009806) in Healthy Participants

NCT04495478 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Ramucirumab - IV
DRUG: Placebo - IV
DRUG: Ramucirumab - SC
DRUG: Placebo - SC

Sponsor

Eli Lilly and Company